356 related articles for article (PubMed ID: 23985043)
21. Basal and pentagastrin-stimulated calcitonin cut-off values in diagnosis of preoperative medullary thyroid cancer.
Kartal Baykan E; Erdoğan M
Turk J Med Sci; 2021 Apr; 51(2):650-656. PubMed ID: 33128357
[TBL] [Abstract][Full Text] [Related]
22. Medullary thyroid carcinoma without marked elevation of calcitonin: a diagnostic and surveillance dilemma.
Wang TS; Ocal IT; Sosa JA; Cox H; Roman S
Thyroid; 2008 Aug; 18(8):889-94. PubMed ID: 18651827
[TBL] [Abstract][Full Text] [Related]
23. Complete surgical lymph node resection does not prevent authentic recurrences of medullary thyroid carcinoma.
Franc S; Niccoli-Sire P; Cohen R; Bardet S; Maes B; Murat A; Krivitzky A; Modigliani E;
Clin Endocrinol (Oxf); 2001 Sep; 55(3):403-9. PubMed ID: 11589685
[TBL] [Abstract][Full Text] [Related]
24. Surgical strategy for the treatment of sporadic medullary thyroid carcinoma: our experience.
Lupone G; Antonino A; Rosato A; Zenone P; Iervolino EM; Grillo M; De Palma M
G Chir; 2012; 33(11-12):395-9. PubMed ID: 23140924
[TBL] [Abstract][Full Text] [Related]
25. Radioactive iodine treatment in medullary thyroid carcinoma.
Faik Erdogan M; Gursoy A; Erdogan G; Kamel N
Nucl Med Commun; 2006 Apr; 27(4):359-62. PubMed ID: 16531922
[TBL] [Abstract][Full Text] [Related]
26. Prospects of remission in medullary thyroid carcinoma according to basal calcitonin level.
Machens A; Schneyer U; Holzhausen HJ; Dralle H
J Clin Endocrinol Metab; 2005 Apr; 90(4):2029-34. PubMed ID: 15634717
[TBL] [Abstract][Full Text] [Related]
27. Identification of occult metastases of medullary thyroid carcinoma by calcitonin measurement in washout fluid from fine needle aspiration of cervical lymph node.
Siqueira D; Rocha AP; Puñales MK; Maia AL
Arq Bras Endocrinol Metabol; 2009 Jun; 53(4):479-81. PubMed ID: 19649389
[TBL] [Abstract][Full Text] [Related]
28. Elevated level of serum carbohydrate antigen 19.9 as predictor of mortality in patients with advanced medullary thyroid cancer.
Elisei R; Lorusso L; Piaggi P; Torregrossa L; Pellegrini G; Molinaro E; Agate L; Bottici V; Pani F; Cacciato Insilla A; Casella F; Ciampi R; Tognetti I; Materazzi G; Basolo F; Romei C
Eur J Endocrinol; 2015 Sep; 173(3):297-304. PubMed ID: 26034076
[TBL] [Abstract][Full Text] [Related]
29. Biomarker-based risk stratification for previously untreated medullary thyroid cancer.
Machens A; Dralle H
J Clin Endocrinol Metab; 2010 Jun; 95(6):2655-63. PubMed ID: 20339026
[TBL] [Abstract][Full Text] [Related]
30. Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders.
Elisei R; Bottici V; Luchetti F; Di Coscio G; Romei C; Grasso L; Miccoli P; Iacconi P; Basolo F; Pinchera A; Pacini F
J Clin Endocrinol Metab; 2004 Jan; 89(1):163-8. PubMed ID: 14715844
[TBL] [Abstract][Full Text] [Related]
31. Identification of occult metastases of medullary thyroid carcinoma by pentagastrin-stimulated intravenous calcitonin sampling followed by targeted surgery.
Schott M; Willenberg HS; Sagert C; Nguyen TB; Schinner S; Cohnen M; Cupisti K; Eisenberger CF; Knoefel WT; Scherbaum WA
Clin Endocrinol (Oxf); 2007 Mar; 66(3):405-9. PubMed ID: 17302876
[TBL] [Abstract][Full Text] [Related]
32. [Pharyngoesophagolaryngeal metastases of medullary thyroid carcinoma. A case report].
Desuter G; Schmitz S; Jamar F; Weynand B; Rahier J; Hamoir M
Ann Endocrinol (Paris); 2003 Dec; 64(6):448-52. PubMed ID: 15067250
[TBL] [Abstract][Full Text] [Related]
33. Lack of elevated serum carcinoembryonic antigen and calcitonin in medullary thyroid carcinoma.
Bockhorn M; Frilling A; Rewerk S; Liedke M; Dirsch O; Schmid KW; Broelsch CE
Thyroid; 2004 Jun; 14(6):468-70. PubMed ID: 15242577
[TBL] [Abstract][Full Text] [Related]
34.
Souteiro P; Gouveia P; Ferreira G; Belo S; Costa C; Carvalho D; Duarte H; Sampaio IL
Endocrine; 2019 May; 64(2):322-329. PubMed ID: 30684230
[TBL] [Abstract][Full Text] [Related]
35. Diagnosis of medullary thyroid carcinoma by calcitonin measurement in fine-needle aspiration biopsy specimens.
Kudo T; Miyauchi A; Ito Y; Takamura Y; Amino N; Hirokawa M
Thyroid; 2007 Jul; 17(7):635-8. PubMed ID: 17696833
[TBL] [Abstract][Full Text] [Related]
36. Circulating calcitonin and carcinoembryonic antigen m-RNA detected by RT-PCR as tumour markers in medullary thyroid carcinoma.
Bojunga J; Dragan C; Schumm-Draeger PM; Usadel KH; Kusterer K
Br J Cancer; 2001 Nov; 85(10):1546-50. PubMed ID: 11720443
[TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of disseminated tumor cells in the connective tissue of patients with medullary thyroid carcinoma.
Gimm O; Heyn V; Krause U; Sekulla C; Ukkat J; Dralle H
World J Surg; 2006 May; 30(5):847-52. PubMed ID: 16680599
[TBL] [Abstract][Full Text] [Related]
38. Pentagastrin stimulation test and early diagnosis of medullary thyroid carcinoma using an immunoradiometric assay of calcitonin: comparison with genetic screening in hereditary medullary thyroid carcinoma.
Barbot N; Calmettes C; Schuffenecker I; Saint-André JP; Franc B; Rohmer V; Jallet P; Bigorgne JC
J Clin Endocrinol Metab; 1994 Jan; 78(1):114-20. PubMed ID: 7904611
[TBL] [Abstract][Full Text] [Related]
39. The use of preoperative routine measurement of basal serum thyrocalcitonin in candidates for thyroidectomy due to nodular thyroid disorders: results from 2733 consecutive patients.
Chambon G; Alovisetti C; Idoux-Louche C; Reynaud C; Rodier M; Guedj AM; Chapuis H; Lallemant JG; Lallemant B
J Clin Endocrinol Metab; 2011 Jan; 96(1):75-81. PubMed ID: 20881258
[TBL] [Abstract][Full Text] [Related]
40. Utility of proGRP as a tumor marker in the medullary thyroid carcinoma.
Parra-Robert M; Orois A; Augé JM; Halperin I; Filella X; Molina R
Clin Chem Lab Med; 2017 Mar; 55(3):441-446. PubMed ID: 27754959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]